Target Information
Genomines is an innovative deeptech company focused on revolutionizing the sourcing of nickel, a strategic metal essential for the energy transition. Utilizing a breakthrough phytomining approach, Genomines enhances the natural capabilities of plants to absorb metals, enabling the extraction of battery-grade nickel from degraded soils. This method not only promises a faster and cleaner alternative to traditional mining but also offers significant cost advantages, with output projected to be up to 40% lower than the median cost of conventional mining operations.
By developing a scalable platform for nickel extraction, Genomines aims to transform underutilized land into productive
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Similar Deals
Wind
invested in
Genomines
in 2025
in a Series A deal
Disclosed details
Transaction Size: $48M